Jan 28 (Reuters) - The following bids, mergers,
acquisitions and disposals were reported by 0930 GMT on Tuesday:
** Pan-European stock exchange Euronext announced
it would acquire Nasdaq's Nordic power futures
activities, as it seeks to widen its business in the northern
European electricity market.
** Dutch bank ING Groep said it had reached an
agreement to sell its business in Russia to local company Global
Development JSC, leaving the bank with an exposure of 1 billion
euros ($1.04 billion).
** Italy's gas grid operator Snam will sell its
minority stake indirectly held in ADNOC Gas Pipelines to Abu
Dhabi-based investment fund Lunate, Snam said.
** German airline group Lufthansa is in talks with
Spanish carrier Air Europa about the possibility of acquiring a
minority stake, according to two sources with knowledge of the
talks.
** Blue Pool, a Hong Kong-based investment firm backed by
Alibaba co-founder Joe Tsai, has bought a 12% stake in Italian
luxury sneaker makerGolden Goose, the Venice-based brand said.
** Tiger Brands, South Africa's biggest food
producer, said it would sell its 24.4% stake in food producer
Empresas Carozzi back to Chilean parent Carozzi for
$240 million to focus on its domestic business.
** Billionaire Brad Jacobs took his QXO $11 billion
takeover offer for Beacon Roofing to shareholders,
after North America's largest publicly traded distributor of
roofing materials repeatedly rebuffed his offer.
** Eversource Energy ( ES ) said it has agreed to sell its
public water supply unit in a deal valued at $2.4 billion, as
the utility firm aims to pare debt and focus on the core
electric and natural gas businesses.
** U.S. industrial company Emerson Electric ( EMR ) agreed
to pay $7.2 billion to buy the remaining shares in software
supplier AspenTech that it does not already own, the
companies said.
** U.S.-based Diversified Energy ( DEC ) said it will buy
private equity-owned Maverick Natural Resources for $1.28
billion, including debt, to expand into the oil and gas-rich
Permian Basin, sending its shares up 4.3%.
** Sage Therapeutics ( SAGE ) said on Monday that its board
has unanimously rejected Biogen's $469 million offer,
stating it "significantly undervalues" the company and does not
serve shareholders' best interests.
(Compiled by Rajarshi Roy and Kritika Lamba in Bengaluru)